Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors.

Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, Katz A, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria JR. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol. 2012 May; 51(5):575-83.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Carcinoma, Hepatocellular
Cholangiocarcinoma
Cohort Studies
Female
Follow-Up Studies
Humans
Liver Neoplasms
Male
Middle Aged
Prognosis
Radiosurgery
Survival Rate
Young Adult

authors with profiles

Alan R. Katz, MD MPH

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support